| Particulars |
|
|
|
|
Company Name
| Concord Biotech Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
199.40 |
| Sales(₹ Cr.) |
1,055.07 |
NP (₹ Cr.) |
240.92 |
| NP Var% |
-30.00 |
Div% |
755.00 |
| CPS(₹) |
30.10 |
EPS (₹) |
23.00 |
| Traded Value(₹ Lakhs) |
373.66 |
52 Week High |
1,614.00 |
| 52 Week Low |
987.00 |
Price BSE |
1,164.00 |
| Price NSE |
1,164.00 |
Market Capital (₹ Cr.) |
12,176.80 |
| P/C Ratio |
38.60 |
P/E Ratio |
50.50 |
| Price Vs.BV |
5.84 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
312.31 |
| NP(₹ Cr.) |
75.71 |
NP Var % |
20.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
1,085.75 |
| OPM |
42.50 |
NP |
328.71 |
| NP Var% |
-7.56 |
EPS |
28.41 |
| PE |
40.97 |
|
|